Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21091674 | HLA-DRB1*04 | onychomycosis | Ashkenazi | NA | NA | unclassified | |
| studies have suggested an autosomal dominant pattern of inheritance and human leukocyte antigen dr4 (hla-dr4) has been shown to protect against onychomycosis in an ashkenazi jewish population.aimthis study investigates hla class ii association in a mexican mestizo population with trichophyton rubrum onychomycosis. | |||||||
| 21091674 | HLA-DR6 (BROAD ANTIGEN) | onychomycosis | Ashkenazi | NA | NA | unclassified | |
| these results suggest that hla-dr6 confers protection against the development of onychomycosis in a mexican mestizo population. | |||||||
| 24686315 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | onychomycosis | NA | NA | NA | unclassified | |
| there are also specific human leukocyte antigen genotypes that are more common in individuals and families with a high prevalence of onychomycosis. | |||||||
| 21150717 | HLA-A (HLA-A) | biliary tract cancer | NA | gemcitabine | NA | positive+negation | |
| human leukocyte antigen (hla)-a 0201, hla-a 0206, and/or hla-a 2402-positive patients with inoperable advanced pancreatic or biliary tract cancer who had not previously been treated with gem were eligible for this study. | |||||||
| 28130311 | HLA-DR (HLA-DR) | acute-on-chronic liver failure | NA | hepatitis | rs3129859 | only_studied | |
| genome-wide association study identifies hla-dr variants conferring risk of hbv-related acute-on-chronic liver failure. | |||||||
| 21208643 | HLA-DR (HLA-DR) | megacolon | NA | NA | NA | unclassified | |
| our results indicate that only enteric glial cells of chagasic patients with megacolon express hla-dr complex class ii and costimulatory molecules, and hence they present the attributes necessary to act as antigen-presenting cells. | |||||||
| 21217043 | HLA-DR (HLA-DR) | histiocytic sarcomas | NA | NA | NA | unclassified | |
| most of the pleomorphic neoplastic cells in the present cases were immunopositive for monocytic, histiocytic, or both markers, such as human leukocyte antigen (hla)-dr, ionized calcium-binding adaptor molecule 1 (iba1), cluster of differentiation (cd)163, and cd204, except for the neoplastic cells in 2 focal and 2 diffuse histiocytic sarcomas. | |||||||
| 21217043 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | histiocytic sarcomas | NA | NA | NA | unclassified | |
| most of the pleomorphic neoplastic cells in the present cases were immunopositive for monocytic, histiocytic, or both markers, such as human leukocyte antigen (hla)-dr, ionized calcium-binding adaptor molecule 1 (iba1), cluster of differentiation (cd)163, and cd204, except for the neoplastic cells in 2 focal and 2 diffuse histiocytic sarcomas. | |||||||
| 21811055 | HLA-A*24 | primary ovarian insufficiency | Japanese | NA | NA | unclassified | |
| association of primary ovarian insufficiency with a specific human leukocyte antigen haplotype (a*24:02-c*03:03-b*35:01) in japanese women. | |||||||
| 21811055 | HLA-C*03 | primary ovarian insufficiency | Japanese | NA | NA | unclassified | |
| association of primary ovarian insufficiency with a specific human leukocyte antigen haplotype (a*24:02-c*03:03-b*35:01) in japanese women. | |||||||
Copyright 2024